Transforming growth factor-β synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 458, Issue 4, 2015, Pages 777-782

  Nakamura, Ryosuke ^a   Kayamori, Kou ^a   Oue, Erika ^a   Sakamoto, Kei ^a   Harada, Kiyoshi ^a   Yamaguchi, Akira ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Bone resorption; Oral cancer; Osteoclast; Smad2; Stromal cells; TGF 1

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; MESSENGER RNA; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOPROTEIN; PHOSPHORYLATED SMAD2 PROTEIN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MARROW STROMA CELL; CALVARIA; CANCER CELL; CANCER PATIENT; CELL LINE; CELL STIMULATION; CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE ASSOCIATION; FIBROBLAST; GENE EXPRESSION; HSC 3 CELL LINE; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IMMUNOHISTOCHEMISTRY; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ST2 CELL LINE; STROMA CELL; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; COMPLICATION; METABOLISM; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; BONE RESORPTION; CARCINOMA, SQUAMOUS CELL; CELL LINE; CELL LINE, TUMOR; HUMANS; MICE; MOUTH NEOPLASMS; OSTEOCLASTS; RANK LIGAND; SMAD2 PROTEIN; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925537432     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.02.013     Document Type: Article

References (22)

1. J.S. Brown, D. Lowe, N. Kalavrezos, J. D'Souza, P. Magennis, and J. Woolgar Patterns of invasion and routes of tumor entry into the mandible by oral squamous cell carcinoma Head Neck 24 2002 370 383
2. R.J. Shaw, J.S. Brown, J.A. Woolgar, D. Lowe, S.N. Rogers, and E.D. Vaughan The influence of the pattern of mandibular invasion on recurrence and survival in oral squamous cell carcinoma Head Neck 26 2004 861 869
3. J. Quan, N.W. Johnson, G. Zhou, P.G. Parsons, G.M. Boyle, and J. Gao Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms Cancer Metastasis Rev. 31 2012 209 219
4. E. Jimi, H. Furuta, K. Matsuo, K. Tominaga, T. Takahashi, and O. Nakanishi The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma Oral Dis. 17 2011 462 468
5. M. Ishikuro, K. Sakamoto, K. Kayamori, T. Akashi, H. Kanda, T. Izumo, and A. Yamaguchi Significance of the fibrous stroma in bone invasion by human gingival squamous cell carcinomas Bone 43 2008 621 627
6. H. Yasuda, N. Shima, N. Nakagawa, K. Yamaguchi, M. Kinosaki, S. Mochizuki, A. Tomoyasu, K. Yano, M. Goto, A. Murakami, E. Tsuda, T. Morinaga, K. Higashio, N. Udagawa, N. Takahashi, and T. Suda Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc. Natl. Acad. Sci. U S A 95 1998 3597 3602
7. E. Jimi, S. Akiyama, T. Tsurukai, N. Okahashi, K. Kobayashi, N. Udagawa, T. Nishihara, N. Takahashi, and T. Suda Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function J. Immunol. 163 1999 434 442
8. K. Sato, J.W. Lee, K. Sakamoto, T. Iimura, K. Kayamori, H. Yasuda, M. Shindoh, M. Ito, K. Omura, and A. Yamaguchi RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer Am. J. Pathol. 182 2013 1890 1899
9. M.S. Bendre, A.G. Margulies, B. Walser, N.S. Akel, S. Bhattacharrya, R.A. Skinner, F. Swain, V. Ramani, K.S. Mohammad, L.L. Wessner, A. Martinez, T.A. Guise, J.M. Chirgwin, D. Gaddy, and L.J. Suva Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway Cancer Res. 65 2005 11001 11009
10. K. Kayamori, K. Sakamoto, T. Nakashima, H. Takayanagi, K. Morita, K. Omura, S.T. Nguyen, Y. Miki, T. Iimura, A. Himeno, T. Akashi, H. Yamada-Okabe, E. Ogata, and A. Yamaguchi Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells Am. J. Pathol. 176 2010 968 980
11. E. Oue, J.W. Lee, K. Sakamoto, T. Iimura, K. Aoki, K. Kayamori, Y. Michi, M. Yamashiro, K. Harada, T. Amagasa, and A. Yamaguchi CXCL2 synthesized by oral squamous cell carcinoma is involved in cancer-associated bone destruction Biochem. Biophys. Res. Commun. 424 2012 456 461
12. H. Ikushima, and K. Miyazono TGFbeta signalling: a complex web in cancer progression Nat. Rev. Cancer 10 2010 415 424
13. R.L. Elliott, and G.C. Blobe Role of transforming growth factor beta in human cancer J. Clin. Oncol. 23 2005 2078 2093
14. Y. Guo, K. Tiedemann, J.A. Khalil, C. Russo, P.M. Siegel, and S.V. Komarova Osteoclast precursors acquire sensitivity to breast cancer derived factors early in differentiation Bone 43 2008 386 393
15. S. Rafiei, and S.V. Komarova Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells BMC Cancer 13 2013 605
16. T. Yasui, Y. Kadono, M. Nakamura, Y. Oshima, T. Matsumoto, H. Masuda, J. Hirose, Y. Omata, H. Yasuda, T. Imamura, K. Nakamura, and S. Tanaka Regulation of RANKL-induced osteoclastogenesis by TGF-beta through molecular interaction between Smad3 and Traf6 J. Bone Miner. Res. 26 2011 1447 1456
17. A. Gingery, E.W. Bradley, L. Pederson, M. Ruan, N.J. Horwood, and M.J. Oursler TGF-beta coordinately activates TAK1/MEK/AKT/NFkB and SMAD pathways to promote osteoclast survival Exp. Cell Res. 314 2008 2725 2738
18. N.S. Nagaraj, and P.K. Datta Targeting the transforming growth factor-beta signaling pathway in human cancer Expert Opin. Investig. Drugs 19 2010 77 91
19. J.T. Buijs, K.R. Stayrook, and T.A. Guise The role of TGF-beta in bone metastasis: novel therapeutic perspectives Bonekey Rep. 1 2012 96
20. K. Fuller, J.M. Lean, K.E. Bayley, M.R. Wani, and T.J. Chambers A role for TGFbeta(1) in osteoclast differentiation and survival J. Cell. Sci. 113 Pt 13 2000 2445 2453
21. J.M. Quinn, K. Itoh, N. Udagawa, K. Hausler, H. Yasuda, N. Shima, A. Mizuno, K. Higashio, N. Takahashi, T. Suda, T.J. Martin, and M.T. Gillespie Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions J. Bone Miner. Res. 16 2001 1787 1794
22. D. Ozawa, T. Yokobori, M. Sohda, M. Sakai, K. Hara, H. Honjo, H. Kato, T. Miyazaki, and H. Kuwano TGFBI expression in cancer stromal cells is associated with poor prognosis and hematogenous recurrence in esophageal squamous cell carcinoma Ann Surg Oncol. 2014 Dec 2 10.1245/s10434-014-4259-4 [Epub ahead of print] Print ISSN:1068-9265, Online ISSN:1534-4681